A Study to Evaluate the Safety and Immunogeneicity of Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults

PHASE1UnknownINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

April 1, 2019

Study Completion Date

July 25, 2019

Conditions

Pneumococcal Infection

Interventions

BIOLOGICAL

LBVE01

Multivalent pneumococcal conjugate vaccine be administered by Intramuscular injection into the thigh

BIOLOGICAL

LBVE02

Multivalent pneumococcal conjugate vaccine be administered by Intramuscular injection into the thigh

BIOLOGICAL

Prevnar13

13-valent pneumococcal conjugate vaccine be administered by Intramuscular injection into the thigh